Epilepsy Research
Volume 31, Issue 2 , Pages 113-122 , July 1998

Alterations in brain and pituitary β-endorphin content in genetically epilepsy-prone rats

  • J.A Carr

      Affiliations

    • Department of Biological Sciences, Texas Tech University, Box 4-3131, Lubbock, TX 79409-3131, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 806 7422724; fax: +1 806 7422963; e-mail: gtjac@ttacs.ttu.edu
    • ,
  • A.M Carpenter

      Affiliations

    • Department of Biological Sciences, Texas Tech University, Box 4-3131, Lubbock, TX 79409-3131, USA
    • ,
  • M.M D'Souza

      Affiliations

    • Department of Biological Sciences, Texas Tech University, Box 4-3131, Lubbock, TX 79409-3131, USA
    • ,
  • A.R Elmore

      Affiliations

    • Department of Biological Sciences, Texas Tech University, Box 4-3131, Lubbock, TX 79409-3131, USA
    • ,
  • A.T Lovering

      Affiliations

    • Department of Biological Sciences, Texas Tech University, Box 4-3131, Lubbock, TX 79409-3131, USA
    • ,
  • C.E Reigel

      Affiliations

    • Department of Pharmacology, Texas Tech University, Health Sciences Center, Lubbock, TX 79430, USA

Received 15 December 1997 ,Revised 24 February 1998 ,Accepted 24 March 1998.

References 

  1. Bajorek JG, Lomax P. Modulation of spontaneous seizures in the Mongolian gerbil: effects of beta-endorphin. Peptides. 1982;3:83–86
  2. Berman EF, Adler MW. The anticonvulsant effect of opioids and opioid peptides against maximal electroshock seizures in rats. Neuropharmacology. 1984;23:367–371
  3. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248–254
  4. Cain DP, Corcoran ME. Epileptiform effects of met-enkephalin, β-endorphin and morphine: kindling of generalized seizures and potentiation of epileptiform effects by handling. Brain Res. 1985;338:327–336
  5. Carr JA, Saland LC, Samora A, Tejeda D. Effects of the enkephalin analog (d-Met2, Pro5)-enkephalinamide on α-melanocyte-stimulating hormone secretion. Regul. Pept. 1993;47:141–150
  6. Chakravarty DN, Faingold CL, Terry WJ, Naritoku DK. Audiogenic seizures in genetically epilepsy prone rat induce c-fos proto-oncogene expression in the inferior colliculus and periaqueductal gray. Soc. Neurosci. Abstr. 1993;19:605
  7. Conway EL, Maccarrone C, Jarrott B, Louis WJ. Comparison of β-endorphin immunoreactivity in hypothalamic and brainstem nuclei of normotensive and age-matched hypertensive rat strains. Neurochem. Int. 1986;9:273–279
  8. Gebhart GF, Mitchell CL. The effect of adrenalectomy on morphine analgesia and tolerance development in rats. Eur. J. Pharmacol. 1972;18:37–42
  9. Harrison MB, Shumate MD, Lothman EW. Opioid peptide expression in models of chronic temporal lobe epilepsy. Neuroscience. 1995;65:785–795
  10. Henriksen SJ, Bloom FE, McCoy F, Ling N, Guillemin R. β-Endorphin induces non-convulsive limbic seizures. Proc. Natl. Acad. Sci. USA. 1978;75:5221–5225
  11. Holaday JW, Loh HH, Li CH. Unique behavioral effects of β-endorphin and their relationship to thermoregulation and hypothalamic function. Life Sci. 1978;22:1525–1536
  12. Holaday JW, Tortella FC, Meyerhoff JL, Belenky GL, Hitzemann RJ. Electroconvulsive shock activates endogenous opioid systems: behavioral and biochemical correlates. Ann. New York Acad. Sci. 1986;467:249–255
  13. Houser CR, Miyashiro JE, Swartz BE, Walsh GO, Rich JR, Delgado-Escueta AV. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J. Neurosci. 1990;10:267–282
  14. Jobe PC, Picchioni AL, Chin L. Role of norepinephrine in audiogenic seizure in the rat. J. Pharmacol. Exp. Ther. 1973;184:1–10
  15. Joseph SA, Pilcher WH, Knigge K. Anatomy of the corticotropin-releasing factor and opiomelanocortin systems of the brain. Fed. Proc. 1985;44:100–107
  16. Lee RJ, McCabe RT, Wamsley JK, Olsen RW, Lomax P. Opioid receptor alterations in a genetic model of generalized epilepsy. Brain Res. 1986;380:76–82
  17. Lee RJ, Hong J-S, McGinty JF, Lomax P. Increased enkephalin and dynorphin immunoreactivity in the hippocampus of seizure sensitive Mongolian gerbils. Brain Res. 1987;401:353–358
  18. Lewis VA, Gebhart GF. Evaluation of the periaqueductal central gray (PAG) as a morphine-specific locus of action and examination of morphine-induced and stimulation-produced analgesia at coincident PAG loci. Brain Res. 1977;124:283–303
  19. Long JB, Tortella FC. Effects of adrenalectomy and hypophysectomy on postictal seizure protection. Brain Res. 1987;402:155–159
  20. McCown TJ, Duncan GE, Johnson KB, Breese GR. Metabolic and functional mapping of the neural network subserving inferior collicular seizure generalization. Brain Res. 1995;701:117–128
  21. Millington WR, Mueller GP, O'Donohue TL. Regional heterogeneity in the ratio of α-MSH:β-endorphin in rat brain. Peptides. 1984;5:841–843
  22. Mueller GP. Attenuated pituitary β-endorphin release in estrogen-treated rats. Proc. Soc. Exp. Biol. Med. 1980;165:75–81
  23. O'Donohue TL, Dorsa DM. The opiomelanotropinergic neuronal and endocrine systems. Peptides. 1982;3:353–395
  24. Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 1973;59:449–450
  25. Palkovits, M., Brownstein, M.J., 1988. Maps and Guide to Microdissection of the Rat Brain. Elsevier, New York.
  26. Patel VK, Abbott LC, Rattan AK, Tejwani GA. Increased methionine-enkephalin levels in genetically epileptic (tg/tg) mice. Brain Res. Bull. 1991;27:849–852
  27. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
  28. Pettibone DJ, Mueller GP. Differential effects of adrenergic agents on plasma levels of immunoreactive β-endorphin and α-melanotropin in rats. Proc. Soc. Exp. Biol. Med. 1984;176:168–174
  29. Pieretti S, Di Giannuario A, Loizzo A, Sagratella S, Scotti De Carolis A, Capasso A, et al. Dexamethasone prevents epileptiform activity induced by morphine in in vivo and in vitro experiments. J. Pharmacol. Exp. Ther. 1992;263:830–839
  30. Prezwlocka B, Stala L, Prezwlocki R. The effect of various opiate agonists on the seizure threshold in the rat. Is dynorphin an endogenous anticonvulsant?. Life Sci. 1983;33:595–598
  31. Puglisi-Allegra S, Castellano C, Csanyl V, Doka A, Oliverio A. Opioid antagonism of electroshock-induced seizures. Pharmacol. Biochem. Behav. 1984;20:767–769
  32. Rees H, Ang L-C, Shul DD, George DH, Begley H, McConnell T. Increase in enkephalin-like immunoreactivity in hippocampi of adults with generalized epilepsy. Brain Res. 1994;652:113–119
  33. Reigel CE, Dailey JW, Jobe PC. The genetically epilepsy-prone rat: an overview of seizure prone characteristics and responsiveness to anticonvulsant drugs. Life Sci. 1986;39:763–774
  34. Reigel CE, Jobe PC, Dailey JW, Stewart JJ. Responsiveness of genetically epilepsy-prone rats to intracerebroventricular morphine-induced convulsions. Life Sci. 1988;42:1743–1749
  35. Ribak CE, Manio AL, Navetta MS, Gall CM. In situ hybridization for c-fos mRNA reveals the involvement of the superior colliculus in the propagation of seizure activity in genetically epilepsy prone rats. Epilepsy Res. 1997;26:397–406
  36. Saland LC, Carr JA, Samora A, Benavidez S, Tejeda D. Interaction of corticotropin-releasing factor (CRF) and alpha-helical CRF on rat neurointermediate lobes: in vitro studies. Neuropeptides. 1991;19:213–221
  37. Savage DD, Reigel CE, Jobe PC. The development of kindled seizures is accelerated in the genetically epilepsy-prone rat. Life Sci. 1986;39:879–886
  38. Savage DD, Mills SA, Jobe PC, Reigel CE. Elevation of naloxone-sensitive [3H]dihydromorphine binding in hippocampal formation of genetically epilepsy-prone rats. Life Sci. 1988;43:239–246
  39. Shehab S, Coffey P, Dean P, Regrave P. Regional expression of fos-like immunoreactivity following seizures induced by pentylenetetrazole and maximal electroshock. Exp. Neurol. 1992;118:261–274
  40. Smith DJ, Robertson B, Monroe PJ, Taylor DA, Leedham JA, Cabral JDY. Opioid receptors mediating antinociception from β-endorphin and morphine in the periaqueductal gray (PAG). Neuropharmacology. 1992;31:37–50
  41. Snead OC, Bearden LJ. The epileptogenic spectrum of opiate agonists. Neuropharmacology. 1982;21:1137–1144
  42. Tortella FC, Long JB. Endogenous anticonvulsant substance in rat cerebrospinal fluid after a generalized seizure. Science. 1985;228:1106–1108
  43. Tortella FC, Long JB. Characterization of opioid peptide-like anticonvulsant activity in rat cerebrospinal fluid. Brain Res. 1988;456:139–146
  44. Tortella FC, Cowan A, Adler MW. Comparison of the anticonvulsant effects of opioid peptides and etorphine in rats after i.c.v. administration. Life Sci. 1981;10:1039–1045
  45. Tortella FC, Long JB, Holaday JW. Endogenous opioid systems: physiological role in self-limitation of seizures. Brain Res. 1985;332:174–178
  46. Wei E. Morphine analgesia, tolerance and physical dependence in the adrenalectomized rat. Br. J. Pharmacol. 1973;47:693–699
  47. Yeung JC, Yaksh TL, Rudy TA. Concurrent mapping of brain sites for sensitivity to the direct application of morphine and focal electrical stimulation in the production of antinociception in the rat. Pain. 1977;4:23–40
  48. Yoshida M, Taniguchi Y. Projection of pro-opiomelanocortin neurons from the rat arcuate nucleus to the midbrain central gray as demonstrated by double-staining with retrograde labeling and immunohistochemistry. Arch. Histol. Cytol. 1988;51:175–183
  49. Zubieta M, Vindrola O, Talavera E, Asai M, Massarini A, Linares G. Pentylenetetrazol-induced seizures produce an increased release of ir-met-enkephalin from rat striatum in vitro. Brain Res. 1985;360:101–107

PII: S0920-1211(98)00019-9

Epilepsy Research
Volume 31, Issue 2 , Pages 113-122 , July 1998

Article Tools

* Image Usage & Resolution